This research investigates how intracellular lactate influences myoglobin and fatty acid interactions in cardiac ischemia, suggesting potential therapeutic targets.
Cardiac ischemia, triggered by coronary artery occlusion, induces a metabolic shift from aerobic to anaerobic respiration, elevating intracellular lactate (LAC) levels and lowering pH, positioning LAC as a critical biomarker. This study investigates molecular interactions between LAC, myoglobin (Mb) (essential for oxygen (O 2 ) storage and transport), and energy metabolism-related metabolites, free fatty acids (FA) and acylcarnitines (AC), which are pivotal for elucidating energy dynamics and cell survival under ischemic conditions. We employed isothermal titration calorimetry (ITC), UV-Vis spectroscopy, and oxytherm respirometry to analyze LAC, FA, and AC interactions with Mb and affect O 2 kinetics. The research aims to determine how these molecular interactions influence Mb’s O 2 release capacity and maintain structural integrity, potentially uncovering novel therapeutic targets for ischemia. ITC experiments demonstrated that oxy-Mb avidly binds to LAC ( Kd = 2.1 ± 0.5 μ M), palmitate PLM ( Kd = 19 ± 1.6 μ M), and palmitoylcarnitine PLC ( Kd = 1.9 ± 0.7 μ M) in one-ligand binding studies, with a 1:1 protein-ligand stoichiometry. Surprisingly, in two-ligand binding assays, no detectable interaction was recorded when second ligand (LAC or PLM or PLC) was added to the pre-bound oxy-Mb. Time resolved UV-vis spectroscopy has shown rapid structural changes to oxy-Mb characterized by a blue shift of Soret peak (435 to 422 nm) with reduced intensity and concomitant conversion of oxy-Mb to met-Mb. These changes occurred in both one- and two-ligand interactions. O 2 kinetic studies have revealed that addition of either PLM or PLC to oxy-Mb did not release O 2 . However, addition of LAC to PLM- or PLC-bound oxy-Mb rapidly releases O 2 . Collectively, these findings suggest that under elevated LAC levels, oxy-Mb undergo auto-oxidation (ferrous, Fe 2+ to ferric, Fe 3+ form), abolishing both O 2 and lipid binding, which might influence the dynamics and effectiveness of fuel transfer to mitochondria.
No takes yet. Share an insight, caveat, or question.
Sree V. Chintapalli (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: